Pilot phase I study of gefitinib (GEF) in combination with paclitaxel (PAC) and radiation therapy (RT) in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) and effects on epidermal growth factor receptor (EGFR) signaling pathway

被引：0
|
作者：
Morris, J. C.
Allen, C.
Citrin, D.
Gius, D.
Chen, Z.
Colevas, A. D.
Harold, N.
Rudy, S.
Singh, A. K.
VanWaes, C.
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] NIDCD, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16526
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I study of gefitinib plus celecoxib in patients with metastatic and/or locally recurrent squamous cell carcinoma of the head and neck (SCCHN).
    Wirth, LJ
    Haddad, RI
    Wieczorek, TJ
    Faucher, JL
    Clark, JR
    Norris, CM
    Posner, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 498S - 498S
  • [32] A phase I/II multi-center study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) for patients with locally advanced esophageal squamous cell carcinoma (ESCC).
    Giuroiu, Iulia
    Ku, Geoffrey Yuyat
    Leichman, Lawrence P.
    Du, Kevin Lee
    Oh, Philmo
    Levinson, Benjamin A.
    Iqbal, Syma
    Thomas, Charles R.
    Wu, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [33] A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
    Chun, Stephen G.
    Hughes, Randall
    Sumer, Baran D.
    Myers, Larry L.
    Truelson, John M.
    Khan, Saad A.
    Ma, Tsung-Wei
    Xie, Yang
    Yordy, John S.
    Cooley, Susan
    Wu, Jean
    Choy, Hak
    Nedzi, Lucien A.
    CANCER INVESTIGATION, 2017, 35 (01) : 23 - 31
  • [34] A phase 2 study of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma: ELEVATE HNSCC
    Colevas, A. Dimitrios Dimitrios
    Dinis, Jose Prime
    Chin, Venessa T.
    Costa, Diogo Alpuim
    Park, John J.
    Fang, Bruno
    Phan, Minh Duc
    Zhang, Yiran
    U'Ren, Lance
    Odegard, Jared
    Curtis, Kelly Kevelin
    Pirtle, Erika
    Adkins, Douglas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysis
    Zhang, Shoude
    Chen, Jia
    Jiang, Hua
    Ma, Haina
    Yang, Beibei
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) : 561 - 569
  • [36] Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysis
    Shoude Zhang
    Jia Chen
    Hua Jiang
    Haina Ma
    Beibei Yang
    European Journal of Clinical Pharmacology, 2012, 68 : 561 - 569
  • [37] A phase I study of intra-arterial (IA) cisplatin (C) and accelerated fractionation (AF) radiotherapy (RT) for locally advanced head and neck squamous cell carcinoma (HNSCC)
    Yu, K.
    Yu, S. C.
    Vlantis, A. C.
    Kam, M. K.
    Hui, E. P.
    King, A.
    Tsang, R. K.
    Tse, G. M.
    Mo, F.
    Chan, A. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma
    Steinberg, L
    Hassan, M
    Olmsted, L
    Sharan, V
    Stepnick, D
    Hoppel, C
    Mugharbil, A
    Subramanyan, S
    McGloin, B
    Mackay, W
    Strauss, M
    SEMINARS IN ONCOLOGY, 1997, 24 (06) : S51 - S56
  • [39] Relationship between human papillomavirus (HPV) status, epidermal growth factor receptor (EGFR) and Phospho-EGFR (pEGFR) expression in head and neck squamous cell carcinoma (HNSCC)
    Filion, E. J.
    Kong, C. S.
    Narasimhan, B.
    Cao, H.
    Erickson, J. P.
    Andersson, A.
    Koong, A.
    Pourmand, N.
    Fredriksson, S.
    Le, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S23 - S23
  • [40] A phase I-II trial of gefitinib (IRESSA) and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
    Caponigro, F.
    Franchin, G.
    Rav, V.
    Silvestro, G.
    Morrica, B.
    Romano, C.
    Minatel, E.
    Pepe, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 313 - 313
12345